alexa Personalizing Drug Treatment Using Pharmacometabonomic Approach
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Metabolomics & Systems Biology
March 24-26, 2014 Hilton San Antonio Airport, San Antonio, USA

Baharudin Ibrahim
ScientificTracks Abstracts: Metabolomics
DOI: 10.4172/2153-0769.S1.024
Abstract
Personalized medicine is a medical model designed to customize drug therapies to individual patients using their distinct characteristics including demographics, medical histories and most importantly their molecular information (genetic, protein and metabolic profile). This concept is thought to be a gateway to truly individualized medical treatments. Personalized medicine beliefs that therapy should be based on the principal philosophy of ?every patient has a unique biology and pathophysiology that should be reflected in the choice of pharmacotherapy?, thus resulting in an improved treatment outcome. Recent advances in genetic testing (genomics) have unveiled the potential relations between genetics and treatment response known as pharmacogenetics/pharmacogenomics. However, this method did not take into consideration of functional and environmental aspects which also play major roles in determining individual differences to clinical outcome. These aspects could be investigated and determined by a novel approach called pharmacometabonomic. Pharmacometabonomics, a branch of metabolomics, focuses on the detection of specific biomarkers in the metabolic profile that are associated with the pharmacodynamic/response and/or toxicity of a drug. Molecular information obtained from these analyses may lead to a more targeted therapy including dosing adjustment and therefore may reduce/prevent drug failure, cost and adverse drug reactions. In future, clinical pharmacist will have a wider role in personalized medicine, for example dose adjustment not just based on therapeutic drug monitoring but also based on molecular information. The aim of this presentation is to comprehensively evaluate recent publications to discuss the ability of pharmacometabonomic approach in personalizing drug treatment.
Biography
Baharudin Ibrahim obtained his Bachelor of Pharmacy in 2005 and Master of Pharmacy (Clinical Pharmacy) in 2007 from Universiti Sains Malaysia (USM). His Ph.D. work was on Metabolomics and Respiratory Medicine from University of Manchester in 2011. He has presented many of his works in international conferences such as American Thoracic Society, European Respiratory Society and Metabolomic conferences and published his researches in reputable journals. He is currently working as a Senior Lecturer in Clinical Pharmacy specializing in respiratory medicine in USM. His researches focus on metabolomics and pharmaco-metabonomics to identify biomarkers of diseases and metabolites to predict adverse drug reactions.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords